Delivery Order SPE2DB24D2205-SPE2DB25FEBRF
Award Date
4/29/25
Potential Completion Date
4/30/25
Potential Value
$3.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB24D2011|SPE2DB25FBQRH, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,470.39 delivery order contract is for the supply of 100-count capsules of the medication Vyvanse 30 mg. The contract is a firm fixed-price, non-set-aside arrangement with a completion date of May 2, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This federal contract award, with the ID SPE2DB22D3004|SPE2DB25FPJ94, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,857.45 Firm Fixed Price contract is a Delivery Order for the supply of 4,567,149,641 units of the prescription medication Vyvanse 30 mg capsules. The contract has an ultimate completion date of February 5, 2025. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award, with ID SPE2DB20D2014|SPE2DB25FB63L, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,620.22 firm fixed-price delivery order is for the supply of 4,567,939,735 units of the medication Vyvanse 30 mg capsules. The contract has an ultimate completion date of April 16, 2025 and was awarded on April 15, 2025. This delivery order is part of a larger Indefinite...
This federal contract award, with ID SPE2DB25D3021|SPE2DB25FQYHX, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,742.04 firm fixed-price delivery order is for the supply of 100-count capsules of the medication Vyvanse 30 mg. The contract has an ultimate completion date of May 5, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $10,833.45 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,559,778,029 units of Vyvanse 30 mg capsules. The contract has a firm fixed price and an ultimate completion date of January 31, 2023. This award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999 through November 2026, which...
This federal contract award, valued at $3,567.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Vyvanse 30 mg capsules. The contract is a firm fixed-price delivery order with an ultimate completion date of April 16, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is the prime contractor and holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, with ID SPE2DB22D3301|SPE2DB25FY2NZ, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $4,833.58 firm fixed-price delivery order is for the supply of 4,567,781,802 units of the medication Vyvanse 30 mg capsules. The contract has an ultimate completion date of April 3, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with...
This federal contract award, with ID SPE2DB22D3301|SPE2DB25FY3QY, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,536.64 firm fixed-price delivery order is for the supply of 4,568,000 units of the 40mg capsule formulation of the medication Vyvanse. The contract has an ultimate completion date of April 23, 2025 and does not utilize any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This federal contract award, with ID SPE2DB22D3019|SPE2DB25FK3NF, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $8,291.24 firm-fixed-price delivery order is for the supply of 4,568,104,039 units of the prescription drug Vyvanse 30 mg capsules. The contract has an ultimate completion date of April 28, 2025 and was awarded on April 25, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,486.46 firm-fixed-price delivery order contract is for the supply of 4,567,299,122 units of Vyvanse 10 mg capsules. The contract has an ultimate completion date of February 19, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...